University of Pennsylvania researchers employed artificial intelligence to analyze more than 400,000 Reddit posts discussing the GLP-1 drugs semaglutide and tirzepatide, both used for weight loss and diabetes treatment. The study aimed to identify patient-reported symptoms and side effects that may not be fully captured in clinical trials or regulatory documents. The research highlights a gap between controlled clinical trial environments and real-world patient experiences shared on social media platforms. This AI-driven approach to pharmacovigilance demonstrates how analyzing large-scale social media data can supplement traditional drug safety monitoring methods.
AI-Powered Analysis of Patient-Reported Experiences on Reddit
- ▪Penn researchers analyzed Reddit posts to identify patient-reported symptoms associated with semaglutide and tirzepatide
- ▪Penn researchers used AI to analyze more than 400,000 Reddit posts about GLP-1 drugs
Identification of Unreported GLP-1 Drug Side Effects
- ▪Penn researchers identified patient-reported symptoms associated with GLP-1 drugs that may not be fully captured in clinical trials
- ▪Semaglutide is a GLP-1 weight-loss and diabetes drug
Limitations of Traditional Clinical Trials and Regulatory Monitoring
- ▪Clinical trials may not fully capture patient-reported symptoms associated with GLP-1 drugs semaglutide and tirzepatide
Perspective of University of Pennsylvania researchers
- ▪AI analysis of social media posts can identify patient-reported drug side effects missed by traditional clinical trials
- ▪Reddit posts provide a valuable data source for understanding real-world patient experiences with GLP-1 medications
Perspective of GLP-1 drug patients
- ▪Social media platforms like Reddit serve as venues where GLP-1 drug users share experiences not captured by formal medical reporting
- ▪Patients taking semaglutide and tirzepatide report symptoms on Reddit that are not fully documented in clinical trials
Story comments
Loading comments…